Final analysis: A randomized, blinded, placebo (P)-controlled phase III study of adjuvant postoperative lapatinib (L) with concurrent chemotherapy and radiation therapy (CH-RT) in high-risk patients with squamous cell carcinoma of the head and neck (SCCHN).

被引：11

作者：

Harrington, Kevin J.

Temam, Stephane

D'Cruz, Anil

Jain, Minish Mahendra

D'Onofrio, Ida

Manikhas, Georgy M.

Horvai, Geza

Sun, Yan

Dietzsch, Stefan

Dubinsky, Pavol

Holeckova, Petra

Mehanna, Hisham

El-Hariry, Iman

Franklin, Natalie

Biswas-Baldwin, Nigel

Legenne, Philippe

Wissel, Paul Stephen

Netherway, Thelma

Santillana, Sergio

Bourhis, Jean

机构：

[1] Inst Canc Res, London SW3 6JB, England

[2] Royal Marsden Hosp, London SW3 6JJ, England

[3] Inst Gustave Roussy, Villejuif, France

[4] Tata Mem Hosp, Bombay 400012, Maharashtra, India

[5] Ruby Hall Clin, Pune, Maharashtra, India

[6] Hop Forcilles, Paris, France

[7] St Petersburg City Oncol Dispensary, St Petersburg, Russia

[8] Szent Imre Univ Teaching Hosp, Budapest, Hungary

[9] Beijing Canc Hosp, Beijing, Peoples R China

[10] Hosp & Policlin Radiat Therapy & Radiooncol, Leipzig, Germany

[11] East Slovakia Canc Inst, Kosice, Slovakia

[12] Inst Radiat Oncol Hosp Na Bulovce, Prague, Czech Republic

[13] Charles Univ Prague, Fac Med 1, Prague, Czech Republic

[14] Univ Birmingham, Inst Head & Neck Studies & Educ, Birmingham, W Midlands, England

[15] Synta Pharmaceut Inc, Lexington, MA USA

[16] GlaxoSmithKline, Uxbridge, Middx, England

[17] GlaxoSmithKline, Philadelphia, PA USA

[18] CHU Vaudois, Lausanne, Switzerland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.6005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6005

引用

页数：1